Apexium Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Sell |
830
-65
| -7% | -$26.4K | 0.02% | 222 |
|
|
2025
Q1 | $446K | Buy |
895
+91
| +11% | +$45.3K | 0.03% | 183 |
|
|
2024
Q4 | $419K | Buy |
804
+14
| +2% | +$7.29K | 0.03% | 179 |
|
|
2024
Q3 | $489K | Hold |
790
| – | – | 0.03% | 143 |
|
|
2024
Q2 | $437K | Sell |
790
-16
| -2% | -$8.85K | 0.03% | 146 |
|
|
2024
Q1 | $469K | Sell |
806
-1,484
| -65% | -$863K | 0.04% | 145 |
|
|
2023
Q4 | $1.22M | Buy |
2,290
+1,536
| +204% | +$815K | 0.09% | 103 |
|
|
2023
Q3 | $382K | Buy |
754
+24
| +3% | +$12.2K | 0.04% | 151 |
|
|
2023
Q2 | $381K | Buy |
730
+92
| +14% | +$48K | 0.03% | 156 |
|
|
2023
Q1 | $368K | Sell |
638
-11
| -2% | -$6.34K | 0.04% | 153 |
|
|
2022
Q4 | $357K | Sell |
649
-65
| -9% | -$35.8K | 0.04% | 153 |
|
|
2022
Q3 | $362K | Buy |
+714
| New | +$362K | 0.05% | 141 |
|